Please login to the form below

Not currently logged in
Email:
Password:

TB

This page shows the latest TB news and features for those working in and with pharma, biotech and healthcare.

Roche collaborates with Global Fund to strengthen critical diagnostics infrastructure

Roche collaborates with Global Fund to strengthen critical diagnostics infrastructure

The partnership is focused on helping patients with HIV and TB in low- and middle-income countries. ... He added: “We are pleased to partner with Roche in expanding access to diagnostics tools for HIV and TB.

Latest news

  • GSK licenses its tuberculosis vaccine to Gates MRI GSK licenses its tuberculosis vaccine to Gates MRI

    According to the World Health Organization (WHO), TB remains one of the top ten causes of death worldwide, with around 10 million new cases of the infection reported in 2018 and ... older people, who accounted for 89% of people who fell ill with TB in

  • GSK's pivotal TB vaccine could prevent millions of deaths GSK's pivotal TB vaccine could prevent millions of deaths

    GlaxoSmithKline has announced that its IAVI-partnered experimental tuberculosis (TB) vaccine candidate significantly reduced the occurrence of pulmonary tuberculosis disease. ... the only available vaccine, BCG, not providing a proven and consistent

  • J&J pledges $500m investment into HIV and tuberculosis R&D J&J pledges $500m investment into HIV and tuberculosis R&D

    In the TB therapy area, J&J will work with partners to improve detection methods for undiagnosed cases of the disease, and broaden the access to its targeted TB medicine bedaquiline – ... It also plans to accelerate R&D efforts to aid in the discovery

  • Gates’ non-profit biotech for poverty diseases sets out its stall at BIO Gates’ non-profit biotech for poverty diseases sets out its stall at BIO

    out research studies in western Kenya and her father’s battle with TB. ... number of avoidable deaths each year - 1.7m in the case of TB and around half a million apiece from malaria and diarrhoea/enteric diseases.

  • J&J expands its TB research programme J&J expands its TB research programme

    Johnson and Johnson (J&J) has partnered with the Institute of Microbial Technology (IMTECH), part of the Council of Scientific and Industrial Research (CSIR), to develop new treatments for tuberculosis (TB). ... Paul Stoffels, chief scientific officer at

More from news
Approximately 6 fully matching, plus 60 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
The Good Ideas Group

Remarkable but responsible creative work. We're most passionate about the pursuit of original, powerful ideas that our clients can harness...

Latest intelligence

William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...
Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...